Neelon/Champagne Confusion Scale

Abstract

The Neelon/Champagne Confusion Scale (commonly known by the acronym NEECHAM Confusion Scale) is an established, clinician-administered observational rating scale designed for the rapid bedside assessment, early detection, and continuous monitoring of acute confusion and delirium in hospitalized adult and geriatric populations. Developed by Virginia J. Neelon, Sandra G. Funk, John R. Carlson, and Mary T. Champagne in 1989, and subsequently validated cross-nationally (including the widely cited Dutch adaptation by Koen Milisen and colleagues in 1999), the scale addresses a critical clinical vulnerability: the pervasive under-recognition of acute neurocognitive decline in acute and long-term care environments. The NEECHAM comprises nine operationalized items organized across three distinct, interrelated domains: Subscale I: Information Processing (evaluating attention, verbal communication, and memory/orientation; score range 0–14); Subscale II: Behavior (assessing general motor posture and movement, sensory-motor command adherence, and verbal/physical social decorum; score range 0–10); and Subscale III: Physiological Control (measuring stability of vital functions, oxygenation status, and urinary continence control; score range 0–6). Total scores span from 0 to 30, where lower scores signify more severe neurocognitive impairment. Standard diagnostic threshold strata identify severe confusion/delirium (scores 0–19), mild or early confusion (scores 20–24), high risk or vulnerability for confusion (scores 25–26), and normal cognitive functioning (scores 27–30). Psychometric evaluations consistently demonstrate robust internal consistency (Cronbach’s α ranging between .85 and .93), high inter-rater reliability (intraclass correlation coefficients and Cohen’s κ exceeding .85 to .96), and strong convergent validity against DSM criteria and the Confusion Assessment Method (CAM). Sensitivity values frequently range from 85% to 95% with specificities between 78% and 92%. Requiring no specialized psychological equipment and completing unobtrusively during routine nursing care within four to ten minutes, the NEECHAM serves as a cornerstone psychometric instrument bridging neurobehavioral assessment and acute physiological monitoring.

Keywords

Neelon/Champagne Confusion Scale, NEECHAM, delirium assessment, acute confusion, cognitive screening, geriatric nursing, psychometrics, information processing, behavioral observation, neurocognitive disorders, acute care, physiological monitoring

Authors

The Neelon/Champagne Confusion Scale was conceptualized, designed, and psychometrically validated through a collaborative interdisciplinary research program at the School of Nursing and Department of Biostatistics at the University of North Carolina at Chapel Hill, United States:

• Virginia J. Neelon, PhD, RN: Associate Professor Emerita of Nursing, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Dr. Neelon is a recognized pioneer in geriatric nursing science, neurobiological mechanisms of acute cognitive disorders, and bedside assessment methodologies.
• Sandra G. Funk, PhD: Professor Emerita and Former Associate Dean for Research, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Dr. Funk is a quantitative psychometrician and biostatistician specializing in measurement design, longitudinal data analysis, and clinical instrumentation.
• John R. Carlson, PhD: Research Associate and Methodologist, School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Specializing in clinical epidemiology and observational instrument calibration.
• Mary T. Champagne, PhD, RN, FAAN: Professor and Dean Emerita, Duke University School of Nursing, Durham, North Carolina, USA; formerly Associate Professor, School of Nursing, University of North Carolina at Chapel Hill. Dr. Champagne is an internationally renowned scholar in evidence-based practice, geriatric care systems, and the organizational translation of delirium prevention protocols.

The cross-cultural adaptation and rigorous European validation was led by:

• Koen Milisen, PhD, RN: Professor of Geriatric Nursing, Department of Public Health and Primary Care, Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium, and Clinical Nurse Scientist, Department of Geriatric Medicine, University Hospitals Leuven.

Purpose

The principal purpose of the Neelon/Champagne Confusion Scale is to operationalize the early detection, systematic monitoring, and trajectory profiling of acute confusion and delirium in acute, subacute, and intensive medical-surgical environments. Delirium represents a medical emergency characterized by an acute onset of cognitive fluctuation, perceptual disturbances, altered levels of consciousness, and pervasive deficits in attentional processing. Historically, epidemiological investigations have established that between 30% and 70% of delirium cases in hospitalized older adults remain undetected or misdiagnosed as preexisting dementia or functional psychiatric disorders by primary healthcare personnel. The primary rationale behind creating the NEECHAM was to resolve this profound diagnostic failure by providing frontline clinicians—specifically registered nurses and bedside multidisciplinary teams—with an objective, non-intrusive, continuous observational framework that does not require artificial or stressful formal mental status testing.

In clinical practice, traditional cognitive batteries such as the Mini-Mental State Examination (MMSE) require explicit, formalized patient interviews involving paper-and-pencil tasks, drawing, and verbal recall. Such direct demands are frequently contraindicated, unfeasible, or invalid when administered to critically ill, post-operative, mechanically ventilated, lethargic, or cognitively fragile patients. The NEECHAM addresses this barrier by harvesting behavioral, interactional, and physiological data directly derived from routine clinical interactions—such as bathing, administering medications, evaluating vital signs, and standard therapeutic conversations. This continuous ecological sampling minimizes patient burden, avoids test-induced catastrophic reactions or anxiety, and facilitates regular repeated administrations across every 8- to 12-hour nursing shift.

From a research perspective, the NEECHAM scale functions as a continuous, sensitive dependent variable capable of detecting sub-syndromal delirium, subtle prodromal fluctuations, and quantitative treatment responses to non-pharmacological delirium bundles (e.g., the Hospital Elder Life Program) or pharmacological therapies. Because the instrument incorporates a stratified continuum (normal, at-risk, mild/early confusion, severe confusion), clinical researchers can track the micro-trajectories of acute neurocognitive deterioration before overt clinical manifestations occur. The instrument thereby serves both as an early warning screening mechanism and as a granular outcome measure in clinical trials targeting cognitive resilience, surgical trauma, systemic inflammation, and perioperative critical care.

Psychological Construct

The Neelon/Champagne Confusion Scale is rooted in a multidimensional conceptualization of acute confusion as a transient, fluctuating neurobehavioral syndrome arising from acute cerebral metabolic insufficiency and impaired central nervous system integrity. Unlike progressive chronic neurodegenerative diseases, acute confusion involves rapid-onset, dynamic disruptions across three core psychological and physiological domains:

1. Information Processing (Cognitive-Perceptual Dimension)

Information processing represents the primary cognitive domain impaired in delirium, reflecting the patient’s capacity to receive, encode, integrate, and interpret sensory environmental inputs. Within the NEECHAM, this construct is decomposed into three distinct functional indicators:

• Attentional Capacity: Attention is the prerequisite neurocognitive gateway. Delirium fundamentally degrades the ascending reticular activating system and prefrontal networks, yielding an inability to focus, sustain, or shift attention. In the NEECHAM, attentional performance is indexed through the speed, consistency, and appropriateness of the patient’s orienting response to environmental and sensory stimuli, ranging from total sensory unresponsiveness to effortless selective and divided attention.
• Verbal Communication and Expression: Language represents an accessible window into cognitive processing speed, semantic coherence, and working memory. The scale gauges receptive and expressive language fluidity. Neurometabolic stress triggers verbal latencies, tangentiality, paraphasic substitutions, incoherent phrases, or mutism, which the instrument captures along an ordinal continuum.
• Memory, Recognition, and Orientation: Disorientation to time, place, and person represents the classical diagnostic marker of confusion. However, NEECHAM emphasizes that spatial and temporal orientation is mediated by both immediate visual/motor recognition of familiar bedside figures and working memory consolidation. Disorientation is scored ordinally, distinguishing between partial situational awareness and profound environmental alienation.

2. Behavior (Psychomotor and Interactional Dimension)

The behavioral construct captures the physical and interactional manifestations of central nervous system disturbance, categorizing alterations in motor planning, motor execution, and social decorum:

• General Motor Activity and Posture: Acute confusion manifests across distinct motoric subtypes: hyperactive (characterized by restlessness, aimless pacing, purposeless picking at bed linens, or severe psychomotor agitation), hypoactive (manifested by profound psychomotor retardation, flat affect, waxy immobility, and flaccidity), or mixed. NEECHAM accommodates both extremes by penalizing aberrant hypoactive and hyperactive states, rewarding only calm, purposeful, and coordinated motor movements.
• Sensory-Motor Command Performance: The capacity to execute simple, volitional motor commands (e.g., “squeeze my fingers,” “reach for your glasses”) tests the integrity of parietal-frontal motor pathways and executive comprehension. Delirious states systematically degrade this sensory-motor translation, yielding delayed, fragmented, or aborted task execution.
• Social Responsiveness and Decorum: Delirium diminishes frontal inhibitory control, frequently causing interpersonal disinhibition, combative agitation, or complete communicative apathy. This indicator assesses social propriety, cooperative compliance with nursing interventions, and interpersonal reciprocity.

3. Physiological Control (Autonomic and Systemic Homeostasis)

Distinct from purely psychiatric cognitive scales, the NEECHAM explicitly incorporates somatic markers reflecting autonomic regulation and physiological decompensation. The underlying hypothesis posits that the brain’s vulnerable microvasculature and neuroendocrine axes fail concurrently with peripheral homeostatic breakdown:

• Stability of Vital Signs: Reflects central autonomic regulation mediated by brainstem and hypothalamic centers. Hemodynamic instability, labile blood pressure, tachypnea, or autonomic dysregulation indicate systemic crisis that directly drives metabolic encephalopathy.
• Oxygenation Status: Hypoxia and subclinical hypoxemia deprive cerebral tissue of requisite ATP, precipitating cellular edema and neurotransmitter failure. NEECHAM documents arterial oxygen saturation and the requirement for supplemental oxygenation as direct proxies of neurochemical vulnerability.
• Urinary Continence Control: Micturition requires coordinated cortical (medial frontal lobe), pontine micturition center, and autonomic sacral pathway interactions. Acute urinary incontinence or sudden neurogenic retention frequently represents an objective early prodromal marker of descending central neurological dysregulation.

Theoretical Framework

The theoretical architecture of the Neelon/Champagne Confusion Scale rests upon the integration of neurobiological vulnerability models, general systems theory, and cognitive energetics theory. Historically, delirium was conceptualized as a nonspecific, monolithic symptom. Neelon and Champagne challenged this reductionist view by framing acute confusion as the clinical manifestation of dynamic failure within an integrated, open biological system undergoing acute stress.

Central to this model is the Pathophysiological Vulnerability and Precipitating Factor Framework, later formalized by Inouye and Charpentier (1996), which shares foundational alignment with Neelon’s early biobehavioral theories. The brain is envisioned as a biological processor reliant on continuous metabolic substrate delivery (glucose, oxygen) and balanced neurotransmitter cascades (predominantly acetylcholine, dopamine, gamma-aminobutyric acid [GABA], and serotonin). When acute systemic perturbations occur—such as sepsis, surgical trauma, electrolyte imbalances, or hypoxemia—the metabolic demand of cerebral tissue outstrips its compensatory physiological reserve. In older adults with reduced neuronal density, silent cerebral infarcts, or cholinergic deficits, systemic inflammation triggers microglial activation, blood-brain barrier permeability, and disrupted neurotransmission, manifesting clinically as impaired information processing.

Additionally, the scale incorporates Robert Hockey’s and Daniel Kahneman’s theories of cognitive energetics and attentional allocation. When biological reserves are compromised, the central executive system suffers an immediate constriction of attentional capacity. Controlled cognitive processing degrades into fragmented automatic responses, diminishing the patient’s capacity to filter external environmental distractors or synthesize complex verbal stimuli. Neelon and colleagues recognized that because behavioral and physiological systems operate in coupled loops, acute cognitive collapse invariably produces measurable autonomic and motor instability. By formalizing this coupling into an operational tripartite model (Information Processing ↔ Behavior ↔ Physiological Control), the NEECHAM embodies a biocognitive systems framework rather than an isolated psychological checklist.

Validity

The psychometric validity of the Neelon/Champagne Confusion Scale has been extensively evaluated across diverse inpatient medical-surgical, intensive care, and orthopedic geriatric cohorts globally.

Criterion and Construct Validity

In the landmark validation study conducted by Neelon, Funk, Carlson, and Champagne (1996) involving hospitalized older patients, the construct validity of the NEECHAM was evaluated against standardized psychiatric evaluations conforming to the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R and DSM-IV) criteria for delirium. The scale demonstrated an exceptional area under the receiver operating characteristic (ROC) curve, typically spanning between .91 and .96 across multiple clinical sites. Using the validated clinical cut-off score of ≤ 24 to designate delirium/acute confusion, early studies reported a diagnostic sensitivity of 87% to 95% and a specificity of 85% to 92%. In specialized orthopedic settings (e.g., Milisen et al., 1999), the Dutch version displayed a sensitivity of 86.8% and a specificity of 78.4% against consensus expert psychiatric diagnoses based on DSM-IV criteria.

Convergent and Discriminant Validity

Convergent validity has been established through strong correlations with parallel neurocognitive and delirium assessment instruments:

• Confusion Assessment Method (CAM): Correlation between the NEECHAM diagnostic categories and the CAM algorithm exhibits substantial to almost perfect agreement, with Cohen’s κ values ranging from .68 to .84.
• Mini-Mental State Examination (MMSE): NEECHAM scores correlate robustly with MMSE total scores in acute settings (Pearson r values typically between .65 and .82, p < .001). However, the NEECHAM systematically avoids the “floor effects” frequently observed with the MMSE among lethargic or non-communicative patients.
• Delirium Rating Scale (DRS / DRS-R-98): Significant inverse correlations (r = −.74 to −.88, p < .001) confirm that higher levels of delirium severity correspond directly to lower NEECHAM composite scores.

Discriminant validity has been confirmed through the instrument’s ability to differentiate acute, fluctuating confusion from stable chronic neurocognitive disorders. While patients with baseline dementia register lower baseline scores in Subscale I (Information Processing), they typically maintain baseline stability in Subscale II (motor coordination) and Subscale III (physiological control). A sudden downward deflection across Subscales II and III reliably discriminates superimposed delirium from underlying dementia alone.

Predictive Validity

The NEECHAM displays strong predictive validity concerning critical hospital outcomes. Longitudinal studies demonstrate that scores falling into the “mild/early confusion” (20–24) and “high risk” (25–26) strata independently predict prolonged hospital length of stay (odds ratios [OR] = 2.1–3.4), heightened risk of in-hospital falls (OR = 3.8), unplanned institutionalization upon discharge, and increased 30-day and 6-month mortality rates.

Reliability

The reliability of the Neelon/Champagne Confusion Scale has been documented extensively across English, Dutch, French, Swedish, and Finnish validation programs, reflecting strong measurement stability across raters, shifts, and clinical cohorts.

Internal Consistency

Estimates of internal consistency across the total 9-item scale demonstrate high homogeneity without redundant item content:

• Original US Validation Studies (Neelon et al., 1992, 1996): Reported Cronbach’s α coefficients between .85 and .90 across general medical-surgical inpatient units.
• Dutch Adaptation (Milisen et al., 1999, 2005): Yielded standardized Cronbach’s α values of .86 to .88 in postoperative hip-fracture patients, with item-total correlations ranging from .42 to .78.
• Subscale Consistency: Subscale I consistently demonstrates the highest internal consistency (α = .82–.89), reflective of the cognitive cluster. Subscale II exhibits moderate to high consistency (α = .73–.81), while Subscale III, capturing heterogeneous autonomic indicators, exhibits moderate internal consistency (α = .58–.68), which is expected for multidimensional physiological parameters.

Inter-Rater and Test-Retest Reliability

Because the NEECHAM is an observational instrument completed by bedside nursing staff, inter-rater reliability is vital:

• Inter-Rater Reliability: Paired simultaneous but independent ratings by registered nurses and research clinical specialists demonstrate Intraclass Correlation Coefficients (ICC) ranging between .88 and .98 (p < .001). Cohen’s κ for categorical classification across diagnostic strata consistently exceeds .80.
• Test-Retest Stability: In medically stable patients evaluated within short intervals (e.g., 2 to 4 hours apart without medical deterioration), test-retest correlation coefficients range from .85 to .93. In fluctuating patients, the scale sensitively tracks hourly changes, accurately reflecting clinical volatility rather than measurement instability.

Factor Analysis

Empirical investigations using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have repeatedly substantiated the structural validity of the tripartite framework hypothesized by Neelon and colleagues.

Exploratory Factor Analysis (EFA)

Early structural investigations utilizing principal component analysis with varimax and oblimin rotations revealed a robust three-factor solution accounting for approximately 62% to 74% of the total variance across clinical samples:

• Factor 1: Information Processing / Cognitive Responsiveness: Encompassing Item 1 (Attention), Item 2 (Verbal Communication), and Item 3 (Memory and Orientation). This primary factor consistently accounts for the largest proportion of explained variance (38% to 45%), with primary factor loadings ranging from .72 to .88.
• Factor 2: Psychomotor Behavior and Social Interaction: Encompassing Item 4 (General Motor Movement), Item 5 (Sensory-Motor Performance), and Item 6 (Verbal/Physical Interaction). This factor accounts for 14% to 18% of the variance, with factor loadings between .64 and .84.
• Factor 3: Physiological Stability: Encompassing Item 7 (Vital Functions), Item 8 (Oxygenation), and Item 9 (Urinary Continence). This factor accounts for 9% to 12% of the variance, with loadings ranging from .55 to .79.

Confirmatory Factor Analysis (CFA)

Subsequent confirmatory studies testing the original three-factor model against alternative unifactorial (single general confusion construct) and two-factor models (cognitive vs. physical) demonstrated superior model fit for the correlated three-factor specification. Representative goodness-of-fit indices across published structural evaluations include:

• Comparative Fit Index (CFI): .94 to .97 (confirming robust fit against baseline null models).
• Tucker-Lewis Index (TLI): .92 to .96.
• Root Mean Square Error of Approximation (RMSEA): .048 to .068 (with 90% confidence intervals bounded below .08, indicating acceptable to close approximation).
• Standardized Root Mean Square Residual (SRMR): .035 to .052.

These structural findings reinforce the psychometric reality that acute delirium manifests as a correlated triad of cognitive, behavioral, and physiological dysregulations rather than an isolated intellectual impairment.

Instrument / Measurement Tool

The Neelon/Champagne Confusion Scale is organized as follows:

• Instrument Type: Clinician-administered observational rating scale (bedside nurse evaluation).
• Assessment Format: Behavioral observation and functional assessment embedded within standard nursing procedures and interactions; requires no patient self-report or written test materials.
• Administration Time: Approximately 4 to 10 minutes during standard bedside rounds.
• Target Population: Hospitalized older adults, post-operative patients, critical care patients, and medical-surgical inpatients at risk of acute neurocognitive decline.
• Total Items: 9 operational items distributed across 3 distinct subscales:
• Subscale Composition:
  • Subscale I: Information Processing (Items 1–3; maximum total = 14 points)
  • Subscale II: Behavior (Items 4–6; maximum total = 10 points)
  • Subscale III: Physiological Control (Items 7–9; maximum total = 6 points)
• Response Format: Subscale-specific point ratings ranging from 0 up to 2, 4, or 5 points per item (total score ranges from 0 to 30).
• Scoring and Directionality: Direct additive summation across all nine items. Higher scores denote optimal cognitive-behavioral-physiological function; lower scores denote severe confusion and neurobehavioral impairment.
• Validated Clinical Cut-Off Strata:
  • 27 – 30 points: Normal cognitive functioning (no evidence of acute confusion).
  • 25 – 26 points: High risk / Vulnerability to confusion (borderline or prodromal state).
  • 20 – 24 points: Mild or early confusion (sub-syndromal or emerging delirium).
  • 0 – 19 points: Severe confusion / Delirium (overt acute neurocognitive failure requiring immediate intervention).

Permissions & Fee and Test Year

The Neelon/Champagne Confusion Scale was formally introduced to the scientific literature in 1989 through foundational presentations and pilot studies, with primary peer-reviewed validation studies published between 1992 and 1996. The official Dutch validation was published by Koen Milisen and colleagues in 1999.

Copyright and Permissibility: The NEECHAM scale is copyrighted by its original creators (Virginia J. Neelon, Sandra G. Funk, John R. Carlson, and Mary T. Champagne). However, the authors established the instrument as a public-access, non-commercial clinical measurement tool to advance patient safety and delirium research. The scale is widely permitted for clinical practice, institutional quality improvement, and non-commercial academic research without royalty fees, provided appropriate scholarly attribution and standard academic citations are maintained. Institutional integration into commercial Electronic Health Record (EHR) systems or proprietary diagnostic software platforms may require direct formal licensing agreements or permissions from the copyright holders or their institutional technology transfer offices.

References

• American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425596
• Champagne, M. T., Neelon, V. J., Funk, S. G., & Carlson, J. R. (1989). A nursing tool to detect acute confusion in the hospitalized elderly. In Proceedings of the Fourth National Conference on Gerontological Nursing (pp. 23–27). University of North Carolina at Chapel Hill.
• Inouye, S. K., & Charpentier, P. A. (1996). Precipitating factors for delirium in hospitalized elderly persons: Predictive model and interrelationship with baseline vulnerability. JAMA, 275(11), 852–857. https://doi.org/10.1001/jama.1996.03530350034031
• Inouye, S. K., van Dyck, C. H., Alessi, C. A., Balkin, S., Siegal, A. P., & Horwitz, R. I. (1990). Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Annals of Internal Medicine, 113(12), 941–948. https://doi.org/10.7326/0003-4819-113-12-941
• Milisen, K., Foreman, M. D., Hendrickx, A., Godderis, J., & De Geest, S. (1999). Psychometric properties of the Dutch version of the NEECHAM Confusion Scale. Tijdschrift voor Gerontologie en Geriatrie, 30(6), 253–260.
• Milisen, K., Foreman, M. D., Godderis, J., Vandermeulen, E., Fischler, B., & Abraham, I. L. (2005). Delirium in the hospitalized elderly: Validity and reliability of the Dutch version of the NEECHAM Confusion Scale. International Journal of Nursing Studies, 42(5), 517–526. https://doi.org/10.1016/j.ijnurstu.2004.09.014
• Neelon, V. J., Champagne, M. T., Carlson, J. R., & Funk, S. G. (1989). The NEECHAM Confusion Scale: Assessing acute confusion in the hospitalized elderly. The Gerontologist, 29(Special Issue), 65A.
• Neelon, V. J., Funk, S. G., Carlson, J. R., & Champagne, M. T. (1992). The NEECHAM Confusion Scale: Construction, validation, and clinical testing. Nursing Research, 41(3), 132–141.
• Neelon, V. J., Champagne, M. T., McConnel, E., Carlson, J., & Funk, S. G. (1996). Use of the NEECHAM Confusion Scale to assess acute confusion in hospitalized older patients. Research in Nursing & Health, 19(4), 297–307. https://doi.org/10.1002/(sici)1098-240x(199608)19:4<297::aid-nur3>3.0.co;2-k
• van de Steeg, L., Ijkema, R., Wagner, C., & Langelaan, M. (2014). The screening performance of the NEECHAM Confusion Scale and the Delirium Observation Screening Scale in hospitalized older patients. BMC Geriatrics, 14, Article 2. https://doi.org/10.1186/1471-2318-14-2

13. Items of the Scale (Questionnaire)